[{"address1": "11711 North Meridian Street", "address2": "Suite 300", "city": "Carmel", "state": "IN", "zip": "46032", "country": "United States", "phone": "317 659 0200", "website": "https://mbxbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. Its lead product candidate is MBX 2109, a parathyroid hormone peptide prodrug, which is in Phase 2 clinical trial for the treatment of chronic hypoparathyroidism. The company is also developing MBX 1416, a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist that is in Phase 1 clinical trial a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery. In addition, it is developing MBX 4291, a lead obesity product candidate, which is in investigational new drug-enabling studies for the treatment of obesity and co-morbidities. The company was founded in 2018 and is based in Carmel, Indiana.", "fullTimeEmployees": 43, "companyOfficers": [{"maxAge": 1, "name": "Mr. Richard B. Bartram CPA", "age": 43, "title": "Chief Financial Officer", "yearBorn": 1981, "fiscalYear": 2024, "totalPay": 642001, "exercisedValue": 0, "unexercisedValue": 3084960}, {"maxAge": 1, "name": "Dr. Salomon  Azoulay M.D.", "age": 67, "title": "Chief Medical Officer", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 520512, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 9, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 24.74, "open": 21.91, "dayLow": 21.9, "dayHigh": 25.695, "regularMarketPreviousClose": 24.74, "regularMarketOpen": 21.91, "regularMarketDayLow": 21.9, "regularMarketDayHigh": 25.695, "payoutRatio": 0.0, "trailingPE": 3.333768, "forwardPE": -10.974249, "volume": 906982, "regularMarketVolume": 906982, "averageVolume": 1295206, "averageVolume10days": 1028760, "averageDailyVolume10Day": 1028760, "bid": 25.41, "ask": 25.68, "bidSize": 2, "askSize": 3, "marketCap": 1148151936, "fiftyTwoWeekLow": 4.807, "fiftyTwoWeekHigh": 26.47, "allTimeHigh": 27.5, "allTimeLow": 4.807, "fiftyDayAverage": 15.5947, "twoHundredDayAverage": 12.057575, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 757101888, "profitMargins": 0.0, "floatShares": 29288874, "sharesOutstanding": 44902302, "sharesShort": 3909541, "sharesShortPriorMonth": 4226517, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.0874, "heldPercentInsiders": 0.027379999, "heldPercentInstitutions": 0.86600995, "shortRatio": 1.55, "shortPercentOfFloat": 0.1401, "impliedSharesOutstanding": 44715498, "bookValue": 8.667, "priceToBook": 2.9502711, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -80495000, "trailingEps": 7.67, "forwardEps": -2.33, "enterpriseToEbitda": -8.354, "52WeekChange": 0.052765965, "SandP52WeekChange": 0.1198014, "quoteType": "EQUITY", "currentPrice": 25.57, "targetHighPrice": 84.0, "targetLowPrice": 30.0, "targetMeanPrice": 60.875, "targetMedianPrice": 61.0, "recommendationMean": 1.25, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 8, "totalCash": 391672992, "totalCashPerShare": 8.723, "ebitda": -90624000, "totalDebt": 623000, "quickRatio": 32.472, "currentRatio": 32.955, "debtToEquity": 0.161, "returnOnAssets": -0.16643, "returnOnEquity": -0.24433, "freeCashflow": -53121752, "operatingCashflow": -77685000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "MBX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "MBX Biosciences, Inc.", "longName": "MBX Biosciences, Inc.", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1762557411, "regularMarketTime": 1762549201, "exchange": "NMS", "messageBoardId": "finmb_613097171", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1295206, "fiftyTwoWeekLowChange": 20.763, "fiftyTwoWeekLowChangePercent": 4.319326, "fiftyTwoWeekRange": "4.807 - 26.47", "fiftyTwoWeekHighChange": -0.8999996, "fiftyTwoWeekHighChangePercent": -0.034000743, "fiftyTwoWeekChangePercent": 5.2765965, "earningsTimestamp": 1762435800, "earningsTimestampStart": 1762435800, "earningsTimestampEnd": 1762435800, "earningsCallTimestampStart": 1754564400, "earningsCallTimestampEnd": 1754564400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 7.67, "epsForward": -2.33, "epsCurrentYear": -2.59709, "priceEpsCurrentYear": -9.845634, "fiftyDayAverageChange": 9.9753, "fiftyDayAverageChangePercent": 0.63965964, "twoHundredDayAverageChange": 13.512424, "twoHundredDayAverageChangePercent": 1.1206585, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-09-13", "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1726234200000, "postMarketChangePercent": -0.27375713, "postMarketPrice": 25.5, "postMarketChange": -0.069999695, "regularMarketChange": 0.83, "regularMarketDayRange": "21.9 - 25.695", "regularMarketChangePercent": 3.35489, "regularMarketPrice": 25.57, "displayName": "MBX Biosciences", "trailingPegRatio": null, "__fetch_time": "2025-11-08"}]